Small molecule modulators of GPR88 activity (agonists, antagonists, or modulators) are of interest as potential agents for the treatment of a variety of psychiatric disorders including schizophrenia. A series of phenylglycinol and phenylamine analogs have been prepared and evaluated for their GPR88 agonist activity and pharmacokinetic (PK) properties.
Keywords: Agonist; GPR88; Phenyl amine; Phenylglycinol; Schizophrenia.
Copyright © 2015 Elsevier Ltd. All rights reserved.